Changeflow GovPing Pharma & Drug Safety Microorganisms Producing 3-Hydroxypropionic Aci...
Routine Notice Added Final

Microorganisms Producing 3-Hydroxypropionic Acid from Glucose

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 25th, 2026
Detected April 2nd, 2026
Email

Summary

The European Patent Office published patent application EP4242312A1 for LG Chem, Ltd., covering engineered microorganisms capable of producing 3-hydroxypropionic acid from glucose. The patent lists three inventors and covers designated contracting states across the EU and EEA.

What changed

The EPO published patent EP4242312A1 granted to LG Chem, Ltd. (applicant) with inventors JO, Jung Hyun, SUNG, Min Kyung, and KIM, Jae Hyung. The invention relates to genetically engineered microorganisms designed to produce 3-hydroxypropionic acid (3-HP) through glucose fermentation. IPC classifications span multiple biotechnology categories including C12N 9/10, 9/04, 9/16, 9/88, 9/02, and 9/12.

Patent publication does not impose compliance obligations on third parties. Entities developing competing bioprocesses for 3-HP production should review this patent to assess potential licensing needs or freedom-to-operate considerations. The designated states include all major EU member states, expanding the geographic scope of the granted exclusive rights.

Source document (simplified)

← EPO Patent Bulletin

MICROORGANISMS HAVING CAPABILITY OF PRODUCING 3-HYDROXYPROPIONIC ACID FROM GLUCOSE AND USES THEREOF

Publication EP4242312A1 Kind: A1 Mar 25, 2026

Applicants

LG Chem, Ltd.

Inventors

JO, Jung Hyun, SUNG, Min Kyung, KIM, Jae Hyung

IPC Classifications

C12N 15/70 20060101AFI20240318BHEP C12N 9/10 20060101ALI20240318BHEP C12N 9/04 20060101ALI20240318BHEP C12N 9/16 20060101ALI20240318BHEP C12N 9/88 20060101ALI20240318BHEP C12N 9/02 20060101ALI20240318BHEP C12N 9/12 20060101ALI20240318BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4242312A1

Who this affects

Applies to
Drug manufacturers Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Biotechnology Patent
Geographic scope
European Union EU

Taxonomy

Primary area
Chemical Manufacturing
Operational domain
Legal
Topics
Biotechnology Pharmaceuticals

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.